Hepatitis B reactivation in a patient receiving radiolabeled rituximab

被引：6

作者：

Soong, YL

Lee, KM

Lui, HF

Chow, WC

Tao, M

Loong, SLE

机构：

[1] Natl Canc Ctr, Dept Radiat Oncol, Singapore 169610, Singapore

[2] Singapore Gen Hosp, Dept Gastroenterol, Singapore 169608, Singapore

[3] Natl Canc Ctr, Dept Med Oncol, Singapore 169610, Singapore

来源：

ANNALS OF HEMATOLOGY | 2005年 / 84卷 / 01期

关键词：

non-Hodgkin's lymphoma; rituximab; radioimmunotherapy; hepatitis;

D O I：

10.1007/s00277-004-0948-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：61 / 62

页数：2

共 4 条

[1] Future directions in radioimmunotherapy for B-cell lymphoma [J].

Horning, SJ .

SEMINARS IN ONCOLOGY, 2003, 30 (06) :29-34

[2] Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report [J].

Ng, HJ ;

Lim, LC .

ANNALS OF HEMATOLOGY, 2001, 80 (09) :549-552

[3] Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy [J].

Westhoff, TH ;

Jochimsen, F ;

Schmittel, A ;

Stöffler-Meilicke, M ;

Schäfer, JH ;

Zidek, W ;

Gerlich, WH ;

Thiel, E .

BLOOD, 2003, 102 (05) :1930-1930

[4] Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma [J].

Witzig, TE ;

Gordon, LI ;

Cabanillas, F ;

Czuczman, MS ;

Emmanouilides, C ;

Joyce, R ;

Pohlman, BL ;

Bartlett, NL ;

Wiseman, GA ;

Padre, N ;

Grillo-López, AJ ;

Multani, P ;

White, CA .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2453-2463

← 1 →